Pfizer tops profit estimates, driven by Prevnar sales

(Reuters) – Pfizer Inc’s quarterly profit topped Wall Street forecasts, driven by stronger-than-expected sales of pneumonia vaccine Prevnar.

Powered by WPeMatico

Scroll to top